Effects of GLP-1 Receptor Agonist on Chronic Axonal Damage, Neurodegeneration, and Cognitive Function in Relapsing-remitting MS (MSGLP): Exploratory, Open Label, Randomized Controlled Trial
Richard Imrich, Ph.D., DSc.,
Adela Penesová, M.D., Ph.D.,
Miroslav Vlček,
Žofia Rádiková, M.D., Ph.D.,
Andrea Havranová, M.S.,
Pavol Šiarnik, M.D., Ph.D.,
Miroslava Hardoňová, M.D.,
Branislav Kollár, M.D., Ph.D.,
Peter Turčáni, M.D., Ph.D.
Affiliations
Richard Imrich, Ph.D., DSc.
Biomedical Research Center, Slovak Academy of Sciences
Adela Penesová, M.D., Ph.D.
Biomedical Research Center, Slovak Academy of Sciences
Miroslav Vlček
Biomedical Research Center, Slovak Academy of Sciences
Žofia Rádiková, M.D., Ph.D.
Biomedical Research Center, Slovak Academy of Sciences
Andrea Havranová, M.S.
Biomedical Research Center, Slovak Academy of Sciences
Pavol Šiarnik, M.D., Ph.D.
1st Department of Neurology, Faculty of Medicine, Comenius University
Miroslava Hardoňová, M.D.
1st Department of Neurology, Faculty of Medicine, Comenius University
Branislav Kollár, M.D., Ph.D.
1st Department of Neurology, Faculty of Medicine, Comenius University
Peter Turčáni, M.D., Ph.D.
1st Department of Neurology, Faculty of Medicine, Comenius University
